Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Nanotech Sciences Corp. Terminates Letter of Intent to Acquire Natcore Technology, Inc.

Abstract:
Nanotech Sciences Corp. (the "Corporation")(TSX VENTURE:NAN.P) a capital pool company, announced today the termination of the letter of intent dated June 17, 2008, as amended (the "Agreement"), pursuant to which the Corporation had conditionally agreed to acquire all of the issued and outstanding securities of Natcore Technology, Inc. ("Natcore") as its qualifying transaction. The Corporation terminated the Agreement because it was unable to satisfactorily complete its due diligence review of Natcore. The Corporation's board of directors have determined that they can not proceed with the transaction as presently structured and that it is in its best interests to terminate the Agreement and to resume the process of identifying and evaluating businesses and assets with a view to completing its potential qualifying transaction.

Nanotech Sciences Corp. Terminates Letter of Intent to Acquire Natcore Technology, Inc.

TORONTO, ON, Canada | Posted on August 16th, 2008

The Corporation has requested repayment of the demand loan dated July 18, 2008 with Natcore in the amount of $100,000, which was provided to Natcore to cover cost associated with completion of the qualifying transaction.

The Corporation will resume its process of identifying and evaluating businesses and assets with a view to completing a potential qualifying transaction.

It is expected that trading will resume in the common shares of the Corporation on the TSX Venture Exchange on or about Tuesday August 19, 2008.

Investors are cautioned that, except as disclosed in the management information circular or filing statement to be prepared in connection with the transaction, any information released or received with respect to the transaction may not be accurate or complete and should not be relied upon. Trading in the securities of a capital pool company should be considered highly speculative.

This news release may contain forward-looking statements that are based on Nanotech's expectations, estimates and projections regarding its business and the economic environment in which it operates. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. Statements speak only as of the date on which they are made, and Nanotech undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances.

The TSX Venture Exchange Inc. has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release. The TSX Venture Exchange Inc. does not accept responsibility for the adequacy or accuracy of this release.

####

Contacts:
Nanotech Sciences Corp.
President & Chief Executive Officer
Scott Walters
(416) 369-0456

Copyright © Marketwire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Researchers develop artificial building blocks of life March 8th, 2024

How surface roughness influences the adhesion of soft materials: Research team discovers universal mechanism that leads to adhesion hysteresis in soft materials March 8th, 2024

Two-dimensional bimetallic selenium-containing metal-organic frameworks and their calcinated derivatives as electrocatalysts for overall water splitting March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

Announcements

What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024

Acquisitions/Mergers/Splits

The concept of creating «brain-on-chip» revealed: A team of scientists is working to create brain-like memristive systems providing the highest degree of adaptability for implementing compact and efficient neural interfaces, new-generation robotics, artificial intelligence, perso May 29th, 2020

180 Degree Capital Corp. Life Science Portfolio Company Enters Into Definitive Agreement to be Acquired May 6th, 2020

180 Degree Capital Corp.’s Portfolio Company, Synacor, Inc., Agrees to Merge with Qumu Corporation in All-Stock Transaction February 11th, 2020

Combination of Nanometrics and Rudolph Technologies to Create Onto Innovation October 16th, 2019

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project